Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / Class 'A' Ordinary Shares
Shares outstanding
386M
Number of holders
20
Total 13F shares, excl. options
6.58M
Shares change
-456K
Total reported value, excl. options
$6.51M
Value change
-$453K
Number of buys
5
Number of sells
-11
Price
$0.99

Significant Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2022

25 filings reported holding TRIB - Trinity Biotech plc - Class 'A' Ordinary Shares as of Q4 2022.
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 6.58M shares of 386M outstanding shares and own 1.7% of the company stock.
Largest 10 shareholders include HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC (1.82M shares), STONEHILL CAPITAL MANAGEMENT LLC (1.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.39M shares), ACADIAN ASSET MANAGEMENT LLC (751K shares), Whitefort Capital Management, LP (410K shares), Aristides Capital LLC (220K shares), ENVESTNET ASSET MANAGEMENT INC (100K shares), MORGAN STANLEY (38.8K shares), Atria Wealth Solutions, Inc. (34.3K shares), and WEALTHSOURCE PARTNERS, LLC (30.2K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.